Bayer (ETR:BAYN) said today it launched the Aleve direct therapy targeted transcutaneous electrical nerve stimulation pain relief device in the U.S. The device is designed as a non-invasive, drug-free method of pain control, specifically targeted at lower back pain, according to the company. “Aleve Direct Therapy puts controllable TENS technology in consumers hands without having to […]
Neuromodulation/Neurostimulation
Nexstim wins CE Mark for brain therapy treatment for chronic neuropathic pain
Brain therapy system developer Nexstim said late last month it won expanded CE Mark approval in the European Union for its Navigated Brain Therapy system, now cleared for the relief of chronic neuropathic pain. The NBT system uses navigated transcranial magnetic stimulation to treat exact areas in the brain using a 3D image rendered from […]
Medtronic warns on wire fracture risk with Activa DBS devices
Medtronic (NYSE:MDT) last month cautioned surgeons to be careful not to implant its Activa deep-brain stimulation devices with sharply bent or kinked wires, after receiving reports of wire fracture. In a June letter to physicians, Fridley, Minn.-based Medtronic said it learned of 16 instances of high impedance measurements that were later found to be caused […]
Helius touts 6-patient study of advanced MS cases
Helius Medical Technologies this week released the result of a 6-patient pilot study of its PoNS therapy used to treat the advanced symptoms of multiple sclerosis, touting improvements in physical, cognitive and quality of life parameters. Data from the study was presented at the 2016 Annual Meeting of the Consortium of Multiple Sclerosis Centers this […]
Nevro takes a hit after insurers deem Senza therapy experimental
Shares in Nevro (NYSE:NVRO) took a hit yesterday after investors learned that a pair of insurers in Pennsylvania and Tennessee tagged therapy using its Senza spinal cord stimulation device as experimental. The Senza device, which won an FDA nod in May 2015, is designed to deliver high-frequency electrical impulses of up to 10,000Hz to the spinal cord to avoid the […]
NeuroMetrix seeks CE Mark for Quell OTC pain relief device
NeuroMetrix (NSDQ:NURO) said today it is seeking CE Mark approval in the European Union for over-the-counter clearance for its Quell wearable chronic pain relief system. The company touted recent studies which indicate that 20-40% of the adult European population suffer fron chronic pain, with an annual financial cost exceeding $250 billion. “Europe is the natural market […]
AtriCure launches cryoanalgesia study
AtriCure (NSDQ:ATRC) said today it launched and enrolled the 1st patient in the Frost trial which aims to examine the use of its CryoIce system designed for the cryoablation of peripheral nerves for the temporary management of post-operative pain. The trial is slated to enroll up to 100 patients to explore the use of cryoanalgesia in addition […]
Axonics launches post-market sacral neuromod OAB study
Axonics Modulation Technologies said today it launched the Relax-OAB 65-patient post-market clinical follow-up study of its SNM system designed to treat overactive bladder. The SNM rechargeable neuromod system is designed to treat overactive bladder, urinary retention and fecal incontinence through sacral nerve stimulation, the Irvine, Calif.-based company said. Axonics touted the 1st implants and enrollments […]
Mainstay Medical pulls in $34m for Reactiv8 neurostim device for chronic pain
Mainstay Medical (EPA:MSTY) said last week that it raised a $34 million (€30 million) equity round for its Reactiv8 neurostimulation device, including a $17 million (€15 million) contribution from family investment fund KCK. Proceeds from the 2.3-million-share flotation, priced at $14.70 apiece (€13.00), are slated for European commercialization of the Reactiv8 device (the system won CE Mark approval in […]
Neuspera closes $9m funding round
NeuSpera Medical closed an $9 million round of equity financing, according to a new SEC filing from the company. NeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation devices, so called “electroceuticals,” using licensed mid-field powering technology. The Santa Clara, Calif.-based company says its implantable module is 100 times smaller than other neuromodulation devices. […]
NeuroMetrix closes $21.3m funding round
NeuroMetrix (NSDQ:NURO) said yesterday it closed a $21.3 million round of funding through the private placement of preferred stock and warrants to support its Quell wearable pain relief device for patients with chronic pain. The Waltham, Mass.-based company said it sold 21,300 shares of Series D convertible preferred stock at $1,000 per share and warrants to […]